// App-Quantinova.ai

2178 : A novel injectable formulation of quercetin reliant on the ability of the drug to complex copper

Researchers

Presenter

  • Kent T. Chen

Principal Investigators

  • Malathi Anantha

  • Ada W.Y. Leung

  • Mohamed Wehbe

  • Brent Sutherland

  • Marcel B. Bally

Medical Centers

  • British Columbia Cancer Research Centre, Vancouber, British Columbia, Canada.

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • B-cell lymphoma 2

Drug/Treatment

  • cisplatin + irinotecan

  • quercetin

Outcome

  • N/A

Study Design

  • Pharmacokinetics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved